research Perifolliculitis Capitis Abscedens et Suffodiens
This article presents a case study of a 25-year-old man with persistent scalp nodules and abscesses with patchy alopecia, unaffected by a course of oral tetracycline.
Search
forResearch
5 / 1000+ resultsresearch Psoriasiform Lesions and Abscesses as Initial Manifestations of Severe Hypothyroidism in a Previously Healthy 15‐Year‐Old Girl
This case report of a 15-year-old girl suggests a direct association between extremely severe hypothyroidism and unusual cutaneous manifestations, such as psoriasiform lesions and abscesses, which improved with thyroid supplementation.
research CLINICAL AND TRICHOSCOPIC EVALUATION OF THE EFFECTIVENESS OF COMPLEX TREATMENT OF ABSCESSING PERIFOLLICULITIS OF THE SCALP
This study at the Dzerkalo Medical Center found that complex therapy for abscessing perifolliculitis of the scalp is more effective in reducing inflammation and follicle destruction compared to basic antibacterial therapy, which was associated with relapses during long-term follow-up.
research Surgery combined with photodynamic therapy for the case of perifolliculitis capitis abscedens et suffodiens: A case report
This case study reports that combining surgery and photodynamic therapy effectively treated a 19-year-old male with perifolliculitis capitis abscedens et suffodiens, proving especially beneficial for patients unresponsive to traditional treatments.
research Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
This case report describes the first instance of ANCA positive vasculitis secondary to Mycobacterium abscessus pulmonary disease, highlighting the complex interplay of immune dysfunction and treatment challenges.
Community Join
2 / 1000+ resultscommunity HopeMed (Hmi115) is pissed at Absci (Abs-201)
HopeMed is upset with Absci for allegedly using misleading information about HMI-115's performance compared to ABS-201. HopeMed plans to take legal action to protect its confidential data and trade secrets.
community Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!
A user is interested in Absci's AI-driven antibody platform, ABS-201, for treating androgenetic alopecia, which shows promising preclinical results and potential for hair regrowth and pigmentation restoration. However, concerns are raised about the drug's development timeline and its advantages compared to existing treatments.
Learn
— no results
Experts
— no results
Clinics
— no results